New 5-Year Data Validates Smith & Nephew Cartilage Repair Implant Performance
By Azmed Devices Editorial Team
Smith & Nephew announced new 5-year study results demonstrating superior pain relief and functional improvements for patients using its Cartiheal Agili-C cartilage repair implant compared to standard surgical care.
Smith & Nephew has announced positive long-term data regarding its Cartiheal Agili-C Cartilage Repair Implant, as detailed in a recent publication in the American Journal of Sports Medicine. According to the company, a multicenter, randomized controlled trial showed that patients treated with the implant achieved higher overall Knee injury and Osteoarthritis Outcome Scores compared to those receiving the surgical standard of care at all follow-up intervals up to 60 months.
According to the company, the five-year study results indicate significant clinical advantages for patients, including superior knee pain relief and improved quality of life. The company reported that patients treated with the implant experienced better functional gains in daily living, sports, and recreational activities at the two, four, and five-year marks. Furthermore, the clinical outcomes remained consistent regardless of whether the patients suffered from osteoarthritis or not, highlighting the implant's versatility.
Experts involved in the clinical research noted the significance of these findings, particularly for patients currently residing in an osteoarthritis treatment gap. According to Smith & Nephew, this group often finds their cartilage too damaged for conventional repair yet not advanced enough for a full joint replacement. The five-year data suggests that the biphasic aragonite-based scaffold provides a durable option to restore function and alleviate pain for these individuals.
The Cartiheal Agili-C implant is an FDA-approved medical technology designed to repair cartilage and restore subchondral bone. Building on this momentum, the company announced that the procedure has been assigned a Category I Current Procedural Terminology code, which is scheduled to take effect on January 1, 2027. This development is expected to improve patient access to the technology, which is currently commercially available in the United States and Puerto Rico.
Source
This article summarizes an official Smith & Nephew announcement. Read the original press release at https://www.smith-nephew.com/en/news/2026/04/21/new-data-for-cartiheal-agili-c-cartilage-repair-implant. Product availability in Azerbaijan is subject to local registration; contact Azmed Devices for current status.
